Glaxo vaccines for stock
Ended Awarded Last action
- Contract number
- HHSP284201800092G
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Administration
Department of Health and Human Services
- Obligated
- $149,238
Award facts
- Contract value 100% obligated
- $149,238.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,443 | |
| Other Administrative Action | $11,669 | |
| Original award | $140,013 |
About this award
Glaxosmithkline, LLC was awarded a $149,238.46 delivery order contract by the Office of the Assistant Secretary for Administration for vaccines inventory stock on March 28, 2018, with a completion date of March 28, 2026. The contract is a firm fixed-price delivery order placed under the company's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which carries a $3.9 billion ceiling. The work will be performed in Research Triangle Park, North Carolina, and no set-aside designation was applied to this award.
This delivery order reflects Glaxosmithkline's established role as a critical supplier of pharmaceutical products and medical countermeasures to federal health agencies. As a foreign-owned pharmaceutical company headquartered in Durham, North Carolina, Glaxosmithkline maintains an extensive portfolio of federal contracts with agencies including the Centers for Disease Control and Prevention, Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services, covering vaccines and related pharmaceutical products that support government immunization programs and emergency preparedness initiatives.
Quick answers
Who was awarded contract HHSP284201800092G?
HHSP284201800092G was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Administration (Department of Health and Human Services) on March 28, 2018.
How much is contract HHSP284201800092G worth?
The government has obligated $149,238 on HHSP284201800092G.
Is contract HHSP284201800092G an order under another contract?
Yes. HHSP284201800092G is a delivery order under V797P2298D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract HHSP284201800092G competed?
The extent of competition for HHSP284201800092G was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award